Glad to share my postdoc work on developing wireless smart bandages for chronic wound management. Thanks to @artemtrotsyuk and @SimiaoNiu for the great collaboration, @zhenanbao and @GeoffreyGurtner for the mentorship, and other coauthors for all the help and support!
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial https://t.co/niqpEexkod
🩺Quand la #VR intègre les salles d'opération:
🗨️"L'@institut_curie est le 1er hôpital à équiper ses chirurgiens avec @AVATAR_MEDICAL (...)on a pu démontrer avec eux que cette technologie de visualisation permet de gagner du temps(...) dans l'interprétation".
🎙️ @Elodie_B_L
"Dans une étude réalisée en Grande-Bretagne, le taux de cancer du col de l'utérus est réduit de 87% en vie réelle chez les femmes qui ont été vaccinées entre 12 et 13 ans contre le papillomavirus humain (HPV)"
https://t.co/NRDAxKALOg
#Vaccination#Cancer#prévention#CrcdcHdF
First author JCO pub. We identify that germline mutations in ATM,BRCA2,CDH1,CHEK2 & PALB2 are associated with increased risk of invasive lobular carcinoma of breast, whereas BRCA1 is not.
@MayoCancerCare@MayoHemeOnc@BasserBRCA@ASCO_pubs@OncoAlert
https://t.co/rd8dqlEdUK
Phase III randomized study evaluated the role of internal mammary node irradiation (IMNI) in node-positive #breastcancer. IMNI did not improve the DFS in unselected patients, but did improve DFS in patients with medially or centrally located tumors https://t.co/tw4ZrHn5wn
Ovarian cancer has its #DESTINY too
The stunning 5-year PFS curves of SOLO1 - maintenance olaparib for BRCA-mutated patients with advanced ovarian cancer
https://t.co/DiO5x6G8If
Cette année encore @Monoprix 🧡 s'engage à nos côtés à l'occasion de la Journée Internationale des Droits des Femmes avec une collection capsule et l'arrondi en caisse ! 🔝👕
Objectif : soutenir le projet #WomenCancerDataLab mené par le Dr @ashamypetit ▶️ https://t.co/1GnV0r5o4S
The NRG-NSABP B-51/RTOG 1304 study is a post neoadjuvant therapy #clinicaltrial, evaluating whether the addition of chestwall and regional nodal radiation therapy will reduce the rate of #BreastCancer recurrence. Learn more: https://t.co/s7n6S4n1bW #BCSM
Emmanuelle Charpentier, awarded this year’s Chemistry Prize, was born in 1968 in Juvisy-sur-Orge, France.
She is Director of the Max Planck Unit for the Science of Pathogens, Berlin, Germany.
https://t.co/We8u3YEtXE
https://t.co/RoRDbHAOHx
#NobelPrize
delays in cancer tt due to covid is a concern. @clare__turnbull and coll reported that 6 months delay in surg leads to 10000 death a year in England. A study from @GustaveRoussy reported at @myESMO found 2-5% increased cancer mortality due to tt delays https://t.co/09ARM0MFd1